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The Ethics of Synthetic Biology 
Contours of an Emerging Discourse 
by Christopher Coenen, Leonhard Hennen and 
Hans-Jürgen Link, ITAS 
Synthetic Biology (SB) is the new kid on the 
block among emerging technosciences that 
are said to have a revolutionary impact and 
the potential to pose major ethical chal-
lenges. SB aims at designing biological sys-
tems for numerous useful purposes, ideally 
starting from scratch and creating new life 
forms. The new EU-funded project SYNTH-
ETHICS will address a variety of ethical, legal 
and social aspects (ELSA) of these ongoing 
and anticipated developments. In the follow-
ing, we will sketch the contours of the 
emerging discourse on the ethics of SB and 
our approach to its analysis. 
1 Synthetic Biology 
Developments in modern biology have reached 
a stage in which more radical design approaches 
than traditional genetic engineering appear to be 
imminent. At the 1999 annual meeting of the 
American Association for the Advancement of 
Science, the famous geneticist Craig Venter, 
who at that time also headed the privately 
funded project that competed in the race for 
complete sequencing of the human genome, 
already talked about the prospects of creating 
synthetic life. He outlined the approach to creat-
ing a true minimal genome by producing a repli-
cating cell with a minimum gene complement 
(i.e. a cell which is bereft of all non-essential 
genes). Venter argued that one would techni-
cally need to synthesise a genome “from 
scratch” and see if it leads to a living organism, 
but he also added that his team had not done this 
so far, due to politically motivated ethical and 
security-related considerations. At the end of the 
same year, his scientific as well as his discursive 
strategy became clearer in two publications in 
the journal Science: A research team from an 
institute founded by Venter reported the results 
of an analysis that suggested that 265 to 350 of 
the 480 protein-coding genes of Mycoplasma 
genitalium are essential under laboratory growth 
conditions; this was accompanied by an article 
on the results of a research project that was con-
ducted on his initiative on the ethics of synthe-
sising a minimal genome (Cho et al. 1999). 
Venter thus included ethical aspects of SB right 
from the beginning of his enterprise, planting 
the seeds of an ethico-political discourse in par-
allel to the technoscientific endeavours. 
Since then, both the research and the 
ethico-political discourse on SB have gained 
impetus at an astounding speed. Venter has con-
tinued to push forward his specific approach, for 
instance by way of a complete chemical synthe-
sis of a chromosome. He has also outlined a 
number of revolutionary implications of future 
developments in SB, including replacing the oil 
industry with a new alternative fuel industry 
based on SB, new insights into the question of 
how life began on Earth, and the digitalisation of 
life (for a lively description, see Edge Founda-
tion 2008). Venter argues that life is machinery 
and now becomes a form of technology as we 
learn how to engineer and reproduce it: This 
opens up the prospect of cell design capabilities 
for a wide variety of very unique utilities. This 
clearly reminds us, and Venter and others draw 
this parallel too, of the early expectations raised 
by nanotechnology, another new technoscience 
whose emergence was accompanied by a multi-
tude of publicly funded and other research ac-
tivities into its ELSA. 
2 Definitions and contours of the field 
While Venter is apparently still the public face 
of SB (Pauwels, Ifrim 2008), SB is neither a 
homogeneous field nor is his approach the only 
research endeavour which is addressed as SB in 
the mass media and the ethico-political dis-
course. Accordingly, when discussing the ELSA 
of the field as well, it is important to make cer-
tain distinctions.1 
The field can very roughly be divided into 
four sub-communities, each of them using dif-
ferent approaches: first, the minimal genome or 
top-down approach taken by Venter, his col-
leagues, and other researchers; second, a bio-
logical bottom-up approach which does not take 
an existing organism as the starting point, but 
plans to use existing biological parts to create 
new cells; third, the “protocell” bottom-up ap-
proach which has the same goal, but starts with 
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basic chemical compounds; and, fourth, an ap-
proach which aims to create new genetic sys-
tems based on chemical modifications of nucleic 
acid bases. Other approaches exist, and it is also 
possible to organise the field and group the sub-
fields differently (cf. e.g. Benner, Sismour 2005; 
Boldt et al. 2009; Luisi 2007). A notion often 
cited in journalistic and other representations of 
the field is that of creating life “from scratch”, 
which was already used by Venter in 1999. This 
notion may, however, be more appropriately 
used only for the bottom-up approaches. In any 
case, there are overlaps between SB and nano-
biotechnology, and SB is also related in some 
sense to various research activities aiming at the 
creation of non-carbon-based life (e.g. in the 
field of “artificial life” [aka “Alife”]). 
With more and more public and private 
money flowing into the field, a dispute over 
“synthetic biology” as a “trademark” may 
evolve (Benner, Sismour 2005, p. 533), as may 
endeavours in “boundary work” similar to those 
in the field of nanotechnology concerning the 
legacy of Eric Drexler’s nanofuturism (cf. e.g. 
Kaiser 2006). Interestingly, SB can not only in 
some respects be understood as a technoscience 
which resembles a broadly defined and highly 
visionary nanotechnology, but it is actually 
praised as such, sometimes (cf. e.g. Bedau, 
Parke 2009) with exact reference to those vi-
sions and ideas that have stirred the most spec-
tacular controversies over nanotechnology.2 
A useful definition of SB is provided by 
Schmidt (2008). This encompasses the endeav-
ours in the above-mentioned four subfields and 
closely related research but, in line with EU 
and other funding schemes, excludes any “al-
ternative biochemistry” approaches (such as 
Alife): “Synthetic biologists use artificial 
molecules to reproduce emergent behaviour 
from natural biology, with the goal of creating 
artificial life or seek interchangeable biological 
parts to assemble them into devices and sys-
tems that function in a manner not found in 
nature” (Schmidt 2008, p. 1). With such a defi-
nition, highly visionary basic research is in-
cluded as well as those research directions that 
are arguably more promising in terms of early 
application and are, as a rule, more similar to 
traditional genetic engineering. 
In any case, in one way or another, the fol-
lowing two features appear to be distinctive for 
SB: The first refers to the notion of synthesis 
and relates to the subject of SB. Its aim thus lies 
in the design of biological components and en-
tire systems with novel properties and functions 
which do not occur in nature. This designation 
makes clear that SB does not merely aim to 
replicate or slightly modify natural organisms, 
but to design new ones with specific applica-
tions in mind. The second definition focuses 
more on the method and procedure of SB and, 
above all, the employment of engineering meth-
ods and principles (cf. Endy 2005). Often men-
tioned here is the fabrication of new biological 
systems by using standardised and modularised 
so-called “biobricks”. The primary objective of 
this methodological approach is to conduct ge-
netic engineering in a more rational and system-
atic way. This second definition also relates to 
synergies realised through the convergence of 
genetics with different areas and disciplines 
such as computational modelling, chemistry, 
and nanotechnology. There is also a close con-
nection between SB and systems biology, which 
is sometimes considered the theoretical and 
analytic framework for SB. 
The above-mentioned vision of an alterna-
tive fuel industry is only one application of SB 
that has been proposed by its champions. Since 
the early days of the emerging discourse, the 
synthetic production of the malaria drug Ar-
temisinin often plays the role of a “poster 
child” of SB (ETC Group 2007). It is almost 
impossible to predict which fields of applica-
tion will be possible in the medium and long 
term and, in light of the visions, these appear to 
be almost unrestricted. Other examples are 
applications in the manufacturing of new mate-
rials (such as biodegradable plastics), the de-
velopment of biosensors and biocomputers, and 
artificial bacteria which dismantle environ-
mental pollutants or deliver human tissue. 
The prospects of such applications, which 
promise solutions to major current problems, 
are sometimes coupled with the proclamation 
that a new technoscientific and industrial revo-
lution could potentially follow from the rise of 
SB and its convergence with other disciplines. 
We here seem to be encountering a dynamics 
of expectations and promises similar and some-
times directly related to developments in other 
discourses, such as that on nanotechnology and 
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its convergence with other key technologies 
(see e.g. Kavli Futures Symposium 2007). 
3 The emerging discourse on the ethics of 
Synthetic Biology 
As mentioned above, ethical aspects of SB 
were taken into consideration very early on 
when it emerged as a new field of research. 
Research on ELSA is now receiving significant 
public funding, and the results of this research 
are being presented in various forums, e.g. at 
major conferences held by the SB community, 
in books (e.g. Bedau, Parkes 2009), and in 
science journals (e.g. Schmidt 2008). At the 
European Union level and in some countries 
(such as Great Britain) at a national level, pro-
jects on ELSA are being funded in close con-
nection with SB projects, or the latter are re-
quired to include professional ELSA expertise 
in their work (cf. Calvert, Martin 2009). A 
range of preliminary studies and policy reports 
on ELSA of synthetic biology have also been 
published by a range of actors, such as civil 
society organisations (ETC Group 2007), pol-
icy advisory boards (e.g. Balmer, Martin 2008; 
Boldt et al. 2009; De Vriend 2006), ethicists 
(e.g. Wolbring 2007), or researchers active in 
the field of SB (e.g. Garfinkel et al. 2007). The 
European Group on Ethics in Science and New 
Technologies (EGE) is currently preparing an 
opinion on SB. Several national research insti-
tutions and associations have prepared reports 
on SB, including its ELSA. 
As part of the Sixth Framework Pro-
gramme for Research and Development (FP6) 
of the European Union, the initiative NEST 
(New and Emerging Science and Technology) 
was launched to promote activities in emerging 
or visionary areas, including SB. In the NEST 
Pathfinder programme, the project SYNBIO-
SAFE broadly addressed ethics, safety and 
security issues and other topics related to SB 
(cf. http://www.synbiosafe.eu). Other relevant 
work on ELSA was or is done, for example, by 
the “Human Practices Thrust” of the Synthetic 
Biology Engineering Research Center (Syn-
BERC) in the U.S., by the Austrian project 
COSY (Communicating Synthetic Biology), 
and by the FP6 project PACE (Programmable 
Artificial Cell Evolution). 
Currently research on the ethics of SB is 
also being funded by the FP7 programme “Sci-
ence in Society”. The project SYNTH-ETHICS 
(Ethical and regulatory issues raised by syn-
thetic biology), which runs until August 2011, 
will analyse a broad range of ethical, legal and 
social implications of SB and make recom-
mendations on the political and social shaping 
of the new field. The Institute for Technology 
Assessment and Systems Analysis (ITAS) at 
the Research Centre Karlsruhe is one of the 
main partners in the project, which is coordi-
nated by the Technical University of Delft and 
also involves the Dutch research institute TNO, 
the University of Padua and the Australian 
National University. The SYNTH-ETHICS 
partners will closely cooperate with SYBHEL 
(Synthetic Biology for Human Health: Ethical 
and Legal Issues), another project in the “Sci-
ence and Society” programme, which will fo-
cus on ethical and legal aspects of medical 
applications of synthetic biology. 
What are the main topics in exploring 
ELSA of SB? Very roughly, two major strands 
of concern and controversy can be discerned,3 
both of them connected with the claim by syn-
thetic biologists of applying an engineering 
approach to biology – and neither of them is 
completely unknown from previous (and ongo-
ing) discussions on genetic engineering and 
other fields such as nanobiotechnology. 
On the one hand there is the “risk issue”, 
well-known under the two headings of “bio-
safety” and “biosecurity” (or “dual use”) from 
related areas such as nanotechnology or genet-
ics. Is there a risk of artificial organisms get-
ting out of hand and developing unintentional 
and unexpected properties that make them det-
rimental to human health and the biosphere? 
And is there a potential for deliberate misuse of 
SB methods, for example for the creation of 
bacteria or viruses for military or terrorist pur-
poses? While the revolutionary character of the 
field is often emphasised by many promoters of 
SB, they tend to argue that these issues have 
been dealt with sufficiently in relation to ge-
netic engineering and that there are no new 
arguments to be added with regard to SB. Es-
pecially on the issue of biosecurity, it is regu-
larly stressed that, given the high expenditures 
and the complexity of SB, deliberate misuse is 
unlikely to appear. However, the ambition of 
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SB to assemble an organism with new proper-
ties by using standardised biological modules 
that are publicly available feeds concerns about 
a new quality of “biosafety” and “biosecurity” 
problems. If the visions of SB become reality, 
then no further big investments and only little 
specific expertise might be needed to produce 
an organism with new properties. 
The second strand of debate is linked to the 
long-standing philosophical question that relates 
to the epistemological fundaments of biology, 
the notion and definition of life. What would 
“artificial life” actually mean? Will impacts of 
SB extend beyond the manipulation of nature 
performed already by genetic engineering or 
traditional breeding? In what way might our 
attitude towards the living be altered, if life in 
the future can be produced artificially? How 
could everyday and scientific distinctions be-
tween the “natural” and the “artificial” change 
and our appraisal of the “natural” life be af-
fected? Are we, as the technofuturist physicist 
Freeman Dyson (2007) argues, “moving rapidly 
into the post-Darwinian era, when species other 
than our own will no longer exist, and the rules 
of Open Source sharing will be extended from 
the exchange of software to the exchange of 
genes” and when biotechnology could “move 
into the mainstream of economic development, 
to help us solve some of our urgent social prob-
lems and ameliorate the human condition all 
over the earth”? And, if so, does the emergence 
of SB “compel us to give a new twist to Freud’s 
title Unbehagen in der Kultur (i.e. Civilization 
and Its Discontents), taking into account that 
now the discontent may shift “from culture to 
nature itself”, leading to a situation where nature 
is no longer the “reliable ‘dense’ background of 
our lives”, but appears “as a fragile mechanism 
which, at any point, can explode in a catastro-
phic direction” (Zizek 2008)? Is there any solid 
basis for our future expectations? Whatever the 
appropriate perspectives and concepts of life and 
nature may be, the jargon used by synthetic 
biologists (such as “living machines”) and the 
far-ranging visions might find their way into 
public awareness. Some of the emergent fears 
are associated with the artificial creation of 
higher life forms – an idea that is far beyond the 
horizon. There is also the question as to the ef-
fect the creation of life could have on the self-
image of mankind (e.g. from homo faber to 
homo creator; cf. Boldt et al. 2009). But even if 
these fears and concerns have only little in 
common with the current state of the art in SB, 
one would be ill-advised to simply push these 
fears aside. In particular from a political per-
spective and with regard to the goal of a public 
dialogue, it is important to investigate the “un-
ease” with SB, such as mistrust towards scien-
tists who appear to be “tampering with Nature” 
or “playing God”. 
As the new kid on the block, SB knows 
more about the social environment it “moves 
to” than its predecessors did; it has had the 
chance to learn lessons from earlier debates. 
However, the conclusions drawn from these 
lessons appear to differ, with some important 
players in the field apparently seeing no need 
to refrain from using even far-flung visions for 
its promotion. Obviously, the discourse on SB 
is another example of the strategic use of rela-
tively far-reaching visions of how to apply the 
results of emerging research areas in the future. 
However, those who are active in the accom-
panying research on emerging technologies 
appear to have learned their lessons too. More 
and more approaches and studies take such 
issues into account as the sociology of expecta-
tions, the pitfalls of a speculative ethics of 
technology, the danger of a vicious circle of 
inflated promises in research policy, and other 
intricacies that one can encounter in ethico-
political discourses on emerging technologies.4 
In addition, investors are advised on what they 
can learn from earlier hype-driven discourses 
such as those on nanotechnology or the Internet 
(Lux Research 2009). 
The project SYNTH-ETHICS will first dis-
tinguish relevant ethical issues related to SB in 
close collaboration with the SB community and 
by means of a literature review. This will be 
followed by an in-depth analysis of selected 
ethical issues. In parallel, the public discourse 
on SB will be analysed from an international 
perspective. This analysis will be conducted by 
ITAS alone and aims to increase existing 
knowledge (cf. Pauwels, Ifrim 2008) of the pub-
lic image of SB in terms of the extent and gen-
eral characteristics of its coverage in the mass 
media. A selection of articles will be analysed 
in-depth, and particularities and dynamics in the 
emergence of the public discourse will be 
sought. Moreover, the project aims (congruently 
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with the goals of the Directorate “Science, 
Economy and Society” of the EU Research Di-
rectorate-General) to identify civil society or-
ganisations for whom the issue of SB and its 
ELSA is of specific interest. This relates to the 
tasks of the project to include a wide variety of 
stakeholders in the discourse and to prepare for 
a rational and informed public deliberation on 
the ELSA of SB. Another goal of SYNTH-
ETHICS is to analyse relevant normative 
frameworks and their adequacy for the chal-
lenges raised by SB. The concept of a normative 
framework (Gorp, Grunwald 2009) includes all 
relevant norms and principles for an existing 
research field, including legal and other social 
regulations as well as codes of conduct. In a 
final step, SYNTH-ETHICS will develop rec-
ommendations targeted at European policy 
makers, the relevant research communities, and 
civil society, based inter alia on the results of a 
larger stakeholder meeting, which will take 
place in Karlsruhe in the winter of 2010/2011. 
Both the meeting and events to promote public 
dialogue that will be organised by the Techni-
cal University of Delft also intend to stimulate 
public discussion and broaden the public dis-
course on SB. 
Notes 
1) For an excellent overview and ethical analysis, 
see Boldt et al. 2009. 
2) Examples for the most spectacular controversies 
over nanotechnology are the visions of Drexler 
and the notion of “converging technologies” that 
was advanced in the U.S. in 2001; cf. e.g. 
Coenen 2009. 
3) For a detailed overview cf. e.g. Boldt et al. 2009. 
4) For a recent comment, see Nordmann, Rip 2009. 
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World Wide Views on Global 
Warming 
Weltweite Bürgerbeteiligung zu 
einem globalen Problem 
von Leonhard Hennen und Martin Knapp, 
ITAS 
Der Klimawandel stellt aufgrund seiner glo-
balen Dimension eine Herausforderung dar, 
die über die Ebene der Nationalstaaten hi-
nausgeht. Folglich sind bei der Erarbeitung 
von Strategien zur Anpassung und von 
Maßnahmen zur Abmilderung der Klimaer-
wärmung neuartige globale Ansätze nötig. 
Das Danish Board of Technology (DBT) hat 
anlässlich der UN-Klimakonferenz im De-
zember 2009 in Kopenhagen ein Projekt 
initiiert, das eine globale öffentliche Platt-
form zur Bürgerbeteiligung schaffen soll. 
Partizipative Verfahren werden im regiona-
len Maßstab bereits erfolgreich in umwelt-
politischen Prozessen eingesetzt, um die 
Akzeptanz für so getroffene Entscheidun-
gen zu erhöhen. Im Vorfeld der Weltklima-
konferenz werden im Rahmen des Projekts 
„World Wide Views on Global Warming“ 
(WWViews) unter Koordination des DBT 
weltweit Bürgerkonferenzen stattfinden, auf 
denen Bürger ihre Meinungen zur Klimapo-
litik äußern können. Das Projekt kann als 
Experiment angesehen werden: Gelingt der 
Versuch, in einer globalisierten Welt auch 
Bürgerbeteiligung weltweit zu begreifen?1 
1 Klimawandel als globale Heraus-
forderung für die Klimapolitik 
Die von Klimaforschern seit geraumer Zeit 
prognostizierte signifikant fortschreitende Er-
höhung der globalen Durchschnittstemperatu-
ren ist mittlerweile deutlich messbar und auch 
von anfangs skeptischen Vertretern der Wis-
senschaft nicht mehr zu leugnen. Obwohl die 
globalen Temperaturen sich erst um einen 
Bruchteil der vorhergesagten Spanne erhöht 
haben, werden bereits jetzt Umweltverände-
rungen in vielen Bereichen deutlich, die ein-
deutig mit dem Klimawandel in Zusammen-
hang gebracht werden können. Für die kom-
menden Jahrzehnte ist bei einem Fortschreiten 
des Temperaturanstiegs mit einer Verstärkung 
dieser Klimafolgen und daraus resultierenden 
